Cargando…

COL1A1-PDGFB fusion uterine sarcoma and its response to Imatinib therapy

Detalles Bibliográficos
Autores principales:	Grindstaff, Samuel L., DiSilvestro, Paul, Quddus, M. Ruhul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752748/ https://www.ncbi.nlm.nih.gov/pubmed/33364286 http://dx.doi.org/10.1016/j.gore.2020.100653

Ejemplares similares

COL1A1-PDGFB fusion uterine fibrosarcoma: A case report with treatment implication
por: Grindstaff, Samuel L., et al.
Publicado: (2019)

COL1A1::PDGFB fusion-associated uterine sarcoma and response to Imatinib: A case report
por: Chapagain, Udita, et al.
Publicado: (2023)

Case Report: A case of COL1A1–PDGFB fusion uterine sarcoma at cervix and insights into the clinical management of rare uterine sarcoma
por: Lu, Linghui, et al.
Publicado: (2023)

Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene
por: Hirose, Takeshi, et al.
Publicado: (2023)

Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-PDGFB rearrangement
por: Makino, Maki, et al.
Publicado: (2016)

First Case of Allochronic Onset of Two Primary Dermatofibrosarcoma Protuberans Lesions Proved by COL1A1-PDGFB Fusion Gene Analysis
por: IKEDA, Ayano, et al.
Publicado: (2022)

Atrophic dermatofibrosarcoma protuberans: report of a case demonstrated by detecting COL1A1-PDGFB rearrangement
por: Qiao, Jianjun, et al.
Publicado: (2012)

Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions
por: Das, Sunetra, et al.
Publicado: (2023)

The impact of morcellation on survival outcomes of undiagnosed uterine sarcoma
por: Raspagliesi, Francesco, et al.
Publicado: (2018)

Complete response of myeloid/lymphoid neoplasms with PDGFRA rearrangement presenting as leukemia/myeloid sarcoma to imatinib monotherapy
por: Ma, Rui, et al.
Publicado: (2019)

The expression of selenium-binding protein 1 is decreased in uterine leiomyoma
por: Zhang, Peng, et al.
Publicado: (2010)

IMATINIB INDUCED LICHEN PLANUS
por: Sudha, R, et al.
Publicado: (2011)

Aldehyde Dehydrogenase 1A1: Friend or Foe to Female Metabolism?
por: Petrosino, Jennifer M., et al.
Publicado: (2014)

Imatinib-induced Melasma-like Pigmentation
por: Subhadarshani, Sweta, et al.
Publicado: (2019)

Lt.-Col. Spencer's Case of Continued Fever
por: McNaught, J. G.
Publicado: (1900)

Imatinib-induced Transverse Melanonychia: An Unusual Presentation
por: Das, Anupam, et al.
Publicado: (2015)

Molecular markers in uterine serous cancer: Correlation between endometrial biopsy and hysterectomy specimens
por: Lokich, Elizabeth, et al.
Publicado: (2019)

Regulation of Transplanted Cell Homing by FGF1 and PDGFB after Doxorubicin Myocardial Injury
por: Baguma-Nibasheka, Mark, et al.
Publicado: (2021)

Cancer Cell-Derived PDGFB Stimulates mTORC1 Activation in Renal Carcinoma
por: Abuhamad, Asmaa Y., et al.
Publicado: (2023)

Human epidermal growth factor receptor 2 (Her2) testing for uterine serous carcinoma: Report of scenarios of unusual overexpression
por: Quddus, M. Ruhul, et al.
Publicado: (2020)

"Surface epithelial changes" in uterine endometrioid carcinoma mimicking micropapillary serous borderline tumor of ovary: report of two cases and review of the literature
por: Singh, Kamaljeet, et al.
Publicado: (2011)

The Perfect Combination: Enhancing Patient Response to PD-1-Based Therapies in Epithelial Ovarian Cancer
por: James, Nicole E., et al.
Publicado: (2020)

Letter from the Professor of Mechanical Dentistry, of the Ohio Col. of Den. Sur
Publicado: (1854)

Familial Brain Calcifications With Leukoencephalopathy: A Novel PDGFB Variant
por: Shen, Jack, et al.
Publicado: (2022)

Imatinib Mesylate-Induced Cutaneous Rash Masquerading as Pityriasis Rosea of Gilbert
por: Verma, Prashant, et al.
Publicado: (2014)

Imatinib is not a potent anti-SARS-CoV-2 drug
por: Zhao, Helong, et al.
Publicado: (2020)

Long-term clinical outcomes of COVID-19 patients treated with imatinib
por: Duijvelaar, Erik, et al.
Publicado: (2022)

COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing's Sarcoma
por: Tang, Min, et al.
Publicado: (2021)

Unique anabolic action of stem cell gene therapy overexpressing PDGFB-DSS6 fusion protein in OVX osteoporosis mouse model
por: Chen, Wanqiu, et al.
Publicado: (2019)

Recent update on XBB.1.5 emerging novel mutation of COVID-19
por: Amin, Ruhul, et al.
Publicado: (2023)

Self-improving dominant dystrophic epidermolysis bullosa: phenotypic variability associated with COL7A1 mutation p.Gly2037Glu
por: Diociaiuti, Andrea, et al.
Publicado: (2021)

Postoperative complication rates and hazards-model survival analysis of revision surgery following occipitocervical and atlanto-axial fusion
por: Yang, Daniel S., et al.
Publicado: (2020)

COX2 Enhances Neovascularization of Inflammatory Tenocytes Through the HIF-1α/VEGFA/PDGFB Pathway
por: Deng, Bin, et al.
Publicado: (2021)

Lrig2-Deficient Mice Are Protected against PDGFB-Induced Glioma
por: Rondahl, Veronica, et al.
Publicado: (2013)

White matter involvement in a family with a novel PDGFB mutation
por: Biancheri, Roberta, et al.
Publicado: (2016)

A systems genetics approach to revealing the Pdgfb molecular network of the retina
por: Li, Shasha, et al.
Publicado: (2020)

Living with primary brain calcification with PDGFB variants: A qualitative study
por: Takeuchi, Tomiko, et al.
Publicado: (2022)

Multiple Eruptive Dermatofibromas Secondary to Imatinib Mesylate in a Patient with Chronic Myeloid Leukemia
por: Lira-Valero, Francisco J, et al.
Publicado: (2021)

Uterine Hemorrhage
por: Weir, John H.
Publicado: (1873)

Novel COL4A1‐VEGFD gene fusion in myofibroma
por: Dachy, Guillaume, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bla29dsf5oi7fqujh9og00dum5